165 related articles for article (PubMed ID: 16409325)
1. Ex vivo biocompatibility tests of regular and white forms of mineral trioxide aggregate.
Ribeiro DA; Matsumoto MA; Duarte MA; Marques ME; Salvadori DM
Int Endod J; 2006 Jan; 39(1):26-30. PubMed ID: 16409325
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity and cytotoxicity of mineral trioxide aggregate and regular and white Portland cements on Chinese hamster ovary (CHO) cells in vitro.
Ribeiro DA; Sugui MM; Matsumoto MA; Duarte MA; Marques ME; Salvadori DM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):258-61. PubMed ID: 16448930
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity in primary human peripheral lymphocytes after exposure to regular and white mineral trioxide aggregate.
da Silva GN; Braz MG; de Camargo EA; Salvadori DM; Ribeiro DA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Nov; 102(5):e50-4. PubMed ID: 17052626
[TBL] [Abstract][Full Text] [Related]
4. Cellular toxicity of mineral trioxide aggregate mixed with an alternative delivery vehicle.
Karimjee CK; Koka S; Rallis DM; Gound TG
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):e115-20. PubMed ID: 16997085
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo assessment of genotoxicity and cytotoxicity in murine fibroblasts exposed to white MTA or white Portland cement with 15% bismuth oxide.
Zeferino EG; Bueno CE; Oyama LM; Ribeiro DA
Int Endod J; 2010 Oct; 43(10):843-8. PubMed ID: 20722754
[TBL] [Abstract][Full Text] [Related]
6. In vitro biocompatibility tests of two commercial types of mineral trioxide aggregate.
Ribeiro DA; Matsumoto MA; Duarte MA; Marques ME; Salvadori DM
Braz Oral Res; 2005; 19(3):183-7. PubMed ID: 16308605
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility in vitro tests of mineral trioxide aggregate and regular and white Portland cements.
Ribeiro DA; Duarte MA; Matsumoto MA; Marques ME; Salvadori DM
J Endod; 2005 Aug; 31(8):605-7. PubMed ID: 16044045
[TBL] [Abstract][Full Text] [Related]
8. Influence of white versus gray mineral trioxide aggregate on inflammatory cells.
Vosoughhosseini S; Lotfi M; Shahi S; Baloo H; Mesgariabbasi M; Saghiri MA; Zand V; Rahimi S; Ranjkesh B
J Endod; 2008 Jun; 34(6):715-7. PubMed ID: 18498897
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and genotoxicity of root canal sealers based on mineral trioxide aggregate.
Bin CV; Valera MC; Camargo SE; Rabelo SB; Silva GO; Balducci I; Camargo CH
J Endod; 2012 Apr; 38(4):495-500. PubMed ID: 22414836
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cytotoxicity of MTA employing various additives.
Jafarnia B; Jiang J; He J; Wang YH; Safavi KE; Zhu Q
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):739-44. PubMed ID: 19426924
[TBL] [Abstract][Full Text] [Related]
11. Behaviour of bone marrow osteoblast-like cells on mineral trioxide aggregate: morphology and expression of type I collagen and bone-related protein mRNAs.
Nakayama A; Ogiso B; Tanabe N; Takeichi O; Matsuzaka K; Inoue T
Int Endod J; 2005 Apr; 38(4):203-10. PubMed ID: 15810969
[TBL] [Abstract][Full Text] [Related]
12. A new resin-bonded retrograde filling material.
Kim M; Ko H; Yang W; Lee Y; Kim S; Mante FK
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov; 108(5):e111-6. PubMed ID: 19836704
[TBL] [Abstract][Full Text] [Related]
13. Effect of mineral trioxide aggregates and Portland cements on inflammatory cells.
Shahi S; Rahimi S; Yavari HR; Mokhtari H; Roshangar L; Abasi MM; Sattari S; Abdolrahimi M
J Endod; 2010 May; 36(5):899-903. PubMed ID: 20416442
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts.
Keiser K; Johnson CC; Tipton DA
J Endod; 2000 May; 26(5):288-91. PubMed ID: 11199738
[TBL] [Abstract][Full Text] [Related]
15. Mineral trioxide aggregate: a review of the constituents and biological properties of the material.
Camilleri J; Pitt Ford TR
Int Endod J; 2006 Oct; 39(10):747-54. PubMed ID: 16948659
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of subcutaneous tissue responses to a novel root-end filling material and white and grey mineral trioxide aggregate.
Parirokh M; Mirsoltani B; Raoof M; Tabrizchi H; Haghdoost AA
Int Endod J; 2011 Apr; 44(4):283-9. PubMed ID: 21091493
[TBL] [Abstract][Full Text] [Related]
17. Investigation of mutagenicity of mineral trioxide aggregate and other commonly used root-end filling materials.
Kettering JD; Torabinejad M
J Endod; 1995 Nov; 21(11):537-42. PubMed ID: 8601761
[TBL] [Abstract][Full Text] [Related]
18. The physical and cytological properties of white MTA mixed with Na2HPO4 as an accelerant.
Ding SJ; Kao CT; Shie MY; Hung C; Huang TH
J Endod; 2008 Jun; 34(6):748-51. PubMed ID: 18498905
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of materials used in perforation repair tested using the V79 fibroblast cell line and the granulocyte-macrophage progenitor cells.
Souza NJ; Justo GZ; Oliveira CR; Haun M; Bincoletto C
Int Endod J; 2006 Jan; 39(1):40-7. PubMed ID: 16409327
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility of furcal perforation repair material using cell culture technique: Ketac Molar versus ProRoot MTA.
Vajrabhaya LO; Korsuwannawong S; Jantarat J; Korre S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec; 102(6):e48-50. PubMed ID: 17138167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
